Anzeige
Mehr »
Login
Montag, 28.04.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
Trump vs. China: Amerikas 1-Billion-Dollar-Verteidigungsoffensive öffnet Global Tactical Metals den Weg zum Antimon-Durchbruch
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A414GM | ISIN: US44984F6097 | Ticker-Symbol:
NASDAQ
25.04.25
21:47 Uhr
2,220 US-Dollar
+0,190
+9,36 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
INVO FERTILITY INC Chart 1 Jahr
5-Tage-Chart
INVO FERTILITY INC 5-Tage-Chart

Aktuelle News zur INVO FERTILITY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoINVO Fertility, Inc.: INVO Fertility Confirms New Nasdaq Trading Symbol of "IVF"-SARASOTA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: NAYA), formerly known as NAYA Biosciences, Inc., a healthcare services fertility company focused on expanding access...
► Artikel lesen
18.04.INVO Fertility, Inc. - 8-K, Current Report2
15.04.NAYA Biosciences spins off cancer drug business 6 months after INVO merger1
15.04.NAYA Biosciences to separate fertility and oncology businesses into distinct operations, changes name to INVO Fertility3
15.04.NAYA Biosciences, Inc.: NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations - Company Renamed "INVO Fertility, Inc."64Public company to operate under new name and concentrate on building, acquiring and operating fertility clinics and the distribution of FDA-cleared INVOcell device Private company to operate as NAYA...
► Artikel lesen
14.04.NAYA Biosciences, Inc. - 8-K, Current Report1
INVO FERTILITY Aktie jetzt für 0€ handeln
31.03.NAYA Biosciences, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT4051
31.03.NAYA Biosciences, Inc. - 8-K, Current Report1
24.03.NAYA Biosciences, Inc. - 8-K, Current Report1
13.03.NAYA Biosciences kündigt Aktienzusammenlegung im Verhältnis 1:12 an1
13.03.NAYA Biosciences, Inc.: NAYA Biosciences Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025116SARASOTA, Fla. and MIAMI, March 13, 2025 (GLOBE NEWSWIRE) -- NAYA Biosciences, Inc. ("NAYA") (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients...
► Artikel lesen
07.03.NAYA Biosciences, Inc. - 8-K, Current Report-
25.02.NAYA Biosciences, Inc. - S-8, Securities to be offered to employees in employee benefit plans-
25.02.NAYA Biosciences, Inc.: NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment173SARASOTA, Fla. and MIAMI, Feb. 25, 2025 (GLOBE NEWSWIRE) -- NAYA Biosciences, Inc. ("NAYA") (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients...
► Artikel lesen
19.02.NAYA Biosciences, Inc.: NAYA Biosciences Announces Nomination of New Board Members1
16.01.NAYA Biosciences, Inc. - 8-K, Current Report-
13.01.NAYA Biosciences To Raise $9.5 Mln Through Public Offering Of Units-
13.01.NAYA Biosciences legt öffentliches Angebot bei 0,70 US-Dollar pro Einheit fest2
13.01.NAYA Biosciences, Inc.: NAYA Biosciences Announces Pricing of $9.5 Million Public Offering1
07.01.NAYA Biosciences, Inc. - 8-K, Current Report-
Seite:  Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1